Ann M. Mauer - Concepedia

Author

Ann M. Mauer

Also Known As

A M Mauer, A Mauer, A. M. Mauer, A. Mauer, A.M Mauer, A.M. Mauer, Ann M Mauer, Ann M. Mauer, Ann Mauer, Dressler, Lynn G.

104

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Chicago Cancer Research Center Northwestern University Medical College of Wisconsin University of Chicago Medical Center

About

Ann M. Mauer is an author at University of Chicago specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	34	1.1K
2	Health Sciences	11	14	421
3	Immunology	4	4	138
4	Gastroenterology	2	2	27
5	Cell Biology	1	1	10

Ann M. Mauer

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer Hyman B. Muss, Donald A. Berry, Constance Cirrincione, New England Journal of Medicine	2009	556
Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Ezra E.W. Cohen, Madeleine Kane, Marcy A. List, Clinical Cancer Research	2005	233
Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer Alex A. Adjei, Ann M. Mauer, Laura M. Bruzek, Journal of Clinical Oncology	2003	213
Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203 Martin J. Edelman, D.K. Watson, Xiaofei Wang, Journal of Clinical Oncology	2008	192
A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer Charles M. Rudin, Gregory A. Otterson, Ann M. Mauer, Annals of Oncology Pilot TrialMedicinePharmacologyPathologyBronchial Neoplasm	2002	154
Phase I study of docetaxel with concomitant thoracic radiation therapy. Ann M. Mauer, Gregory A. Masters, D. Haraf, Journal of Clinical Oncology	1998	148
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer Athanassios Argiris, Ezra E.W. Cohen, Theodore Karrison, Cancer Biology & Therapy	2006	115
Analysis of further disease progression in metastatic non-small cell lung cancer: Implications for locoregional treatment Neil Mehta, Ann M. Mauer, Samuel Hellmän, International Journal of Oncology MedicineMultiple Pulmonary NoduleLocoregional TreatmentMetastatic NsclcPathology	2004	115
A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC) Everett E. Vokes, Ezra E.W. Cohen, Ann M. Mauer, Journal of Clinical Oncology Single Agent ActivityPhase IiMedicineImmunologyPhase Ii Dose	2005	89
A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer Ann M. Mauer, Ezra E.W. Cohen, C. Patrick, Journal of Thoracic Oncology MedicinePathologyPhase Ii StudyBronchial NeoplasmCancer Treatment	2008	88

Page 1